SeaStar Medical Holding Corporation
ICU
$0.6552
$0.04647.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -25.26% | 6.84% | 17.95% | 32.00% | -20.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.18% | 54.11% | 53.77% | 24.51% | -13.77% |
| Operating Income | 3.24% | -51.97% | -51.46% | -24.51% | 13.77% |
| Income Before Tax | 70.32% | 53.30% | 38.08% | -32.39% | -78.93% |
| Income Tax Expenses | -- | 100.00% | -- | -40.00% | -- |
| Earnings from Continuing Operations | 70.29% | 53.27% | 38.08% | -32.24% | -78.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.29% | 53.27% | 38.08% | -32.24% | -78.93% |
| EBIT | 3.24% | -51.97% | -51.46% | -24.51% | 13.77% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 90.75% | 85.34% | 87.85% | 74.96% | 65.27% |
| Normalized Basic EPS | 90.76% | 85.65% | 61.51% | 74.93% | 65.27% |
| EPS Diluted | 90.75% | 85.34% | 87.85% | 74.96% | 65.27% |
| Normalized Diluted EPS | 90.76% | 85.65% | 61.51% | 74.93% | 65.27% |
| Average Basic Shares Outstanding | 221.06% | 218.69% | 409.65% | 428.18% | 415.20% |
| Average Diluted Shares Outstanding | 221.06% | 218.69% | 409.65% | 428.18% | 415.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |